Next, by Michael Crichton

Poor old Michael Crichton - he's really fallen foul of genetic modification

Kim Newman
Tuesday 02 January 2007 01:00 GMT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Though his backlist includes oddments like an inside-the-drug-culture novel, Dealing, a Victorian true-crime piece (The First Great Train Robbery) and a re-telling of Beowulf (Eaters of the Dead), Michael Crichton has mostly retained his place on the bestseller lists by refining the formula he hit on with The Andromeda Strain in 1970.

The usual Crichton tract is a near-future science-fiction chase thriller that extrapolates from cutting-edge concerns and is often tinged with satire or simple grumpiness about the whizzing speed of advances. Once upon a time, when Crichton had a parallel career as a film director, everything he wrote was a sure sell to Hollywood - though a run of flop adaptations has put a crimp in that. He has reacted by delivering books so all-over-the-place that a professional screenwriter would have a hard time wrestling an action movie out of the tangle.

Next is middling Crichton, perhaps because it lacks the simple suspense situation around which most of his books are constructed. It doesn't even have a real focus, as it ties together anecdotes and musings about transgenic creatures (animals with a percentage of human DNA); the harvesting and sale of human tissues without permission; the patenting of elements of the human genome by pharmaceutical interests; the transformation of university research departments into ruthless commercial entities; genetically derived "cures" for behaviours such as drug addiction; and the genetic manipulation of animals or humans for art, business or pranksterism. Then there are the reliably fiendish triple-dealings of sundry big-business baddies, never happier than when they can make a profit while trampling on the rights of nicer-than-nice good folks.

Crichton does eventually get to the plot. A lawyer and her son go on the run, pursued by a bounty hunter, because a court decision against her father implies that a drug company has a legal right to take cells from their bones. But Next spends a lot of time hopping around the world first, with a thread about a talking monkey in Borneo and a sentient parrot in Paris, before the characters converge for a punch-up that settles everything. The good are rewarded and the wicked punished in time to make room for 14 pages of editorial ("Rescind the Bayh-Dole Act") and annotated bibliography. This is a genetically altered dog's breakfast of a book, with a few good jokes and characterisations thinner than a microscope slide.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in